IP Library › Assignment 026547/0599
Patent Assignment
Reel/Frame 026547/0599

Assignment of Assignor's Interest

Recorded: 2011-07-06 Pages: 4
Assignors
STRONG, H ANDREW
Executed: 2011-06-23
CADDEN, SUZANNE
Executed: 2011-06-28
Assignee
QLT INC.
887 GREAT NORTHERN WAY, SUITE 101, VANCOUVER, V5T 4T5, CANADA
Covered Property (1)
Therapeutic Regimen and Methods for Treating or Ameliorating Visual Disorders Associated with an Endogenous Retinoid Deficiency
Patent: 9,173,856 →
Application: 13/090,215 →
Publication: US 2011/0257266
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name May 4, 2017
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 042246/0375 →
Assignment of Assignor's Interest Feb 21, 2019
From: NOVELION THERAPEUTICS INC.
To: RETINAGENIX, LLC
Reel/Frame 048403/0004 →
Assignment of Assignor's Interest Mar 20, 2020
From: RETINAGENIX, LLC
To: RETINAGENIX THERAPEUTICS, INC.
Reel/Frame 052175/0176 →
Assignment of Assignor's Interest Apr 7, 2021
From: RETINAGENIX THERAPEUTICS, INC.
To: RETINAGENIX HOLDINGS LLC
Reel/Frame 055857/0001 →
Assignment of Assignor's Interest Aug 9, 2022
From: RETINAGENIX HOLDINGS LLC
To: ELUMINEX BIOSCIENCES (SUZHOU) LIMITED
Reel/Frame 060763/0001 →